Prostate Cancer

52 competing products in clinical development for Prostate Cancer.

Pipeline by Phase

Pre-clinical2

Phase 18

Phase 1/23

Phase 229

Phase 2/31

Phase 36

Approved3

All Products (52)

Product	Company	Stage	Status	Hype
Ifinatamab deruxtecan + Docetaxel + Prednisone + Rescue Medication	Daiichi Sankyo	Phase 3	Recruiting	47
talazoparib plus enzalutamide + Placebo plus enzalutamide	Astellas Pharma	Phase 3	Active	44
Ra223 + Enzalutamide	Astellas Pharma	Phase 3	Active	44
Enzalutamide + Abiraterone + Placebo for Enzalutamide + Prednisone	Astellas Pharma	Approved	Completed	43
Enzalutamide + Flutamide	Astellas Pharma	Approved	Completed	43
Leuprolide	Astellas Pharma	Approved	Completed	43
Abemaciclib + Placebo + Abiraterone acetate + Prednisone	Eli Lilly	Phase 2/3	Active	42
enzalutamide + abiraterone acetate + prednisone + Leuprolide acetate	Astellas Pharma	Phase 2	Recruiting	42
ASP5541 + Prednisone + Prednisolone + abiraterone acetate + Adrenocorticotropic hormone	Astellas Pharma	Phase 2	Recruiting	42
Pembrolizumab + Enzalutamide	Astellas Pharma	Phase 2	Recruiting	42
fezolinetant - reference formulation + Placebo	Astellas Pharma	Phase 2	Recruiting	42
degarelix + Goserelin	Astellas Pharma	Phase 3	Completed	40
Enzalutamide + Placebo	Astellas Pharma	Phase 3	Completed	40
leuprorelin acetate	Astellas Pharma	Phase 3	Completed	40
ADT+Docetaxel+Enzalutamide	Astellas Pharma	Phase 2	Active	39
Docetaxel + Enzalutamide	Astellas Pharma	Phase 2	Active	39
Enzalutamide capsule	Astellas Pharma	Phase 2	Active	39
degarelix + enzalutamide + trametinib + dasatinib	Astellas Pharma	Phase 2	Active	39
Enzalutamide + Bicalutamide + GnRH analog	Astellas Pharma	Phase 2	Active	39
ASP5541 + Prednisone	Astellas Pharma	Phase 1	Recruiting	36
PRL-02 injection + prednisone + dexamethasone + enzalutamide	Astellas Pharma	Phase 1	Recruiting	36
Pemetrexed	Eli Lilly	Phase 2	Completed	35
exatecan mesylate	Daiichi Sankyo	Phase 2	Completed	35
Enzalutamide	Astellas Pharma	Phase 2	Completed	35
YM155	Astellas Pharma	Phase 2	Completed	35
Enzalutamide + Leuprolide acetate	Astellas Pharma	Phase 2	Completed	35
enzalutamide + Androgen Deprivation	Astellas Pharma	Phase 2	Completed	35
Enzalutamide	Astellas Pharma	Phase 2	Completed	35
CP-461	Astellas Pharma	Phase 2	Completed	35
nivolumab + docetaxel + enzalutamide + rucaparib + prednisone	Astellas Pharma	Phase 2	Completed	35
ELIGARD	Astellas Pharma	Phase 2	Completed	35
YM155	Astellas Pharma	Phase 2	Completed	35
Enzalutamide	Astellas Pharma	Phase 2	Completed	35
Enzalutamide + Leuprolide + Dutasteride	Astellas Pharma	Phase 2	Completed	35
Enzalutamide + Bicalutamide	Astellas Pharma	Phase 2	Completed	35
Zytiga® (Abiraterone Acetate) + SoluMatrix™ (Abiraterone Acetate)	Sun Pharmaceutical	Phase 2	Completed	35
E7389	Eisai	Phase 2	Completed	35
Irofulven + Prednisone + Mitoxantrone + Capecitabine + Irofulven	Eisai	Phase 2	Completed	35
YM 155 + Docetaxel + Prednisone	Astellas Pharma	Phase 1/2	Completed	32
MDV3100	Astellas Pharma	Phase 1/2	Completed	32
IADT	Astellas Pharma	Pre-clinical	Active	30
Enzalutamide + Metformin Hydrochloride	Astellas Pharma	Phase 1	Completed	29
Enzalutamide tablet + Enzalutamide capsule	Astellas Pharma	Phase 1	Completed	29
MDV3100	Astellas Pharma	Phase 1	Completed	29
MDV3100	Astellas Pharma	Phase 1	Completed	29
enzalutamide + enzalutamide Placebo + digoxin + rosuvastatin	Astellas Pharma	Phase 1	Completed	29
AGS-1C4D4	Astellas Pharma	Phase 1	Completed	29
PLX3397	Daiichi Sankyo	Phase 2	Terminated	27
YM598	Astellas Pharma	Phase 2	Terminated	27
Docetaxel + Enzalutamide + Prednisone	Astellas Pharma	Phase 2	Terminated	27
Depo-Eligard®	Astellas Pharma	Pre-clinical	Completed	26
NBTXR3 activated by IMRT only + NBTXR3 activated by Brachytherapy & IMRT	Nanobiotix	Phase 1/2	Terminated	18